Jonathan Aumais

Jonathan Aumais, PhD, is a Senior Patent Agent currently at Genentech, where they provide primary intellectual property support for diverse programs, including engineered T-cell therapies and gene editing technologies. With over 15 years of experience in life sciences IP strategy and patent portfolio management, they have worked at notable organizations like Life Technologies, Thermo Fisher Scientific, and Meyertons, Hood, Kivlin, Kowert & Goetzel, P.C. Jonathan earned a PhD in Molecular and Cellular Biology from Baylor College of Medicine, along with an MSc in Physiology and a BSc in Immunology from McGill University. Their expertise spans U.S. and foreign patent prosecution, innovation harvesting, and counseling on various intellectual property matters.